IRIDEX CORP Current Assets
IRIDEX CORP (IRIX) had Current Assets of $23.96 million as of 2026-07-04, per its 10-Q filed 2026-08-18.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-18
- 2026-07-04: Assets, Current $23.96M.
- 2026-04-04: Assets, Current $24.58M.
- 2026-01-03: Assets, Current $25.25M.
- 2025-09-27: Assets, Current $24.07M.
| Period end | Assets, Current |
|---|---|
| 2026-07-04 | $23.96M 10-Q · filed 2026-08-18 |
| 2026-04-04 | $24.58M 10-Q · filed 2026-05-19 |
| 2026-01-03 | $25.25M 10-Q · filed 2026-08-18 |
| 2025-09-27 | $24.07M 10-Q · filed 2025-11-12 |
| 2025-06-28 | $26.87M 10-Q · filed 2025-08-12 |
| 2025-03-29 | $29.13M 10-Q · filed 2025-05-13 |
| 2024-12-28 | $23.56M 10-K · filed 2026-04-02 |
| 2024-09-28 | $24.34M 10-Q · filed 2024-11-12 |
| 2024-06-29 | $25.01M 10-Q · filed 2024-08-08 |
| 2024-03-30 | $27.58M 10-Q · filed 2024-05-14 |
| 2023-12-30 | $27.45M 10-K · filed 2025-03-27 |
| 2023-09-30 | $27.34M 10-Q · filed 2023-11-20 |
| 2023-07-01 | $30.96M 10-Q · filed 2023-08-10 |
| 2023-04-01 | $34.70M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $35.77M 10-K · filed 2024-03-29 |
| 2022-10-01 | $38.35M 10-Q · filed 2022-11-10 |
| 2022-07-02 | $39.44M 10-Q · filed 2022-08-15 |
| 2022-04-02 | $41.93M 10-Q · filed 2022-05-12 |
| 2022-01-01 | $42.25M 10-K · filed 2023-03-09 |
| 2021-10-02 | $43.91M 10-Q · filed 2021-11-12 |
| 2021-07-03 | $43.73M 10-Q · filed 2021-08-12 |
| 2021-04-03 | $44.22M 10-Q · filed 2021-05-12 |
| 2021-01-02 | $25.36M 10-K · filed 2022-03-15 |
| 2020-09-26 | $25.56M 10-Q · filed 2020-11-10 |
| 2020-06-27 | $25.76M 10-Q · filed 2020-08-07 |
| 2020-03-28 | $26.98M 10-Q · filed 2020-05-12 |
| 2019-12-28 | $30.55M 10-K · filed 2021-03-23 |
| 2019-09-28 | $31.22M 10-Q · filed 2019-11-08 |
| 2019-06-29 | $33.28M 10-Q · filed 2019-08-07 |
| 2019-03-30 | $35.06M 10-Q · filed 2019-05-07 |
| 2018-12-29 | $39.62M 10-K · filed 2020-03-13 |
| 2018-09-29 | $41.37M 10-Q · filed 2018-11-06 |
| 2018-06-30 | $32.93M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $34.91M 10-Q · filed 2018-05-08 |
| 2017-12-30 | $39.45M 10-K · filed 2019-03-29 |
| 2017-09-30 | $41.48M 10-Q · filed 2017-11-07 |
| 2017-07-01 | $43.52M 10-Q · filed 2017-08-08 |
| 2017-04-01 | $45.02M 10-Q · filed 2017-05-09 |
| 2016-12-31 | $45.87M 10-K · filed 2018-03-14 |
| 2016-10-01 | $31.41M 10-Q · filed 2016-11-07 |
| 2016-07-02 | $32.67M 10-Q · filed 2016-08-08 |
| 2016-04-02 | $31.38M 10-Q · filed 2016-05-09 |
| 2016-01-02 | $30.77M 10-K · filed 2017-03-15 |
| 2015-10-03 | $31.42M 10-Q · filed 2015-11-10 |
| 2015-07-04 | $31.93M 10-Q · filed 2015-08-10 |
| 2015-04-04 | $33.21M 10-Q · filed 2015-05-12 |
| 2015-01-03 | $32.89M 10-K · filed 2016-03-31 |
| 2014-09-27 | $30.77M 10-Q · filed 2014-11-03 |
| 2014-06-28 | $30.46M 10-Q · filed 2014-08-04 |
| 2014-03-29 | $31.29M 10-Q · filed 2014-05-05 |
| 2013-12-28 | $31.97M 10-K · filed 2015-04-02 |
| 2013-09-28 | $30.36M 10-Q · filed 2013-11-04 |
| 2013-06-29 | $29.69M 10-Q · filed 2013-08-05 |
| 2013-03-30 | $27.39M 10-Q · filed 2013-05-06 |
| 2012-12-29 | $27.05M 10-K · filed 2014-03-27 |
| 2012-09-29 | $28.61M 10-Q · filed 2012-11-05 |
| 2012-06-30 | $29.03M 10-Q · filed 2012-08-07 |
| 2012-03-31 | $28.61M 10-Q · filed 2012-05-07 |
| 2011-12-31 | $29.51M 10-K · filed 2013-03-28 |
| 2011-10-01 | $28.02M 10-Q · filed 2011-11-04 |
| 2011-07-02 | $27.15M 10-Q · filed 2011-08-04 |
| 2011-01-01 | $26.37M 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |